喹硫平与西酞普兰治疗脑卒中后抑郁症状的临床观察

A Clinical observation of quetiapine and citalopram in the treatment of post-stroke depression.

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2016, 43(1)
作者
作者单位

安徽省芜湖市第四人民医院 ;

摘要
比较空石流平和西改普兰治疗脑卒中后却郁的疗效和安全性。方法 把诊断脑卒中后1中郁的患者112例, 随机分两组, 两纽分别予以空石流平和西改普兰治疗8周。 于治疗前和治疗2、4、8周末,采用汉密尔顿jfF郁量表(HAMD)、生活能力指数量表(ADL)评定疗效,副反应量表(TESS)评定不良反应。结果在治疗8周末,两组HAMD、 ADL评分差异无统计学意义(P均>0.05) ,两组的显效率分别为71.4%和75.0%,差异无统计学意义(P>0.05)。 全石流平组嗜睡和口干多见, 而西西;k普兰组恶心、 v区吐较多 。结论 治疗脑卒中后却郁姿石流平与西改普兰疗效相当,安全可靠,副反应轻微。
Abstract
〇bjective To compare the efficacy and security of quetiapine and citalopram in the treatment ofpost-stroke depression. Method 112 patients with post-stroke depression were divided into two groups which were re- ceived quetiapine or citalopram for8 weeks respectively. And the curative effect and side reaction were evaluated with Hamilton depressive scale(HAMD), activity of Daily Living scale(ADL) and treatment emergent symptom scale(TESS) respectively before and after the treatment in2nd, 4th, 8th weekend. Results After8 weeks treat- ment, there were no significant differences in the score of HAMD and CGI-SI between two groups (P>0.05). The total effective rates of quetiapine and citalopram were71.4% and75.0% respectively, without any statistically sig- nificant difference between groups(P>0.05). Patients in quetiapine group had more drowsiness and dry mouth, yet patients in cita1opram had more nausea and vomiting. Conclusion Quetiapine has a similar efficacy with citato- pram in the treatment of the patients with post-stroke depressions, the security is higher, and the side reaction is slighter.
关键词
喹硫平;西酞普兰;脑卒中后抑郁
KeyWord
Quetiapine; Cita1opram; Post-stroke depression
基金项目
页码 61-62
  • 参考文献
  • 相关文献
  • 引用本文

阳中明*,张 恩,熊 伟, 刘 伟. 喹硫平与西酞普兰治疗脑卒中后抑郁症状的临床观察 [J]. 国际精神病学杂志. 2016; 43; (1). 61 - 62.

  • 文献评论

相关学者

相关机构